🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 13 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/03/1998 | 57,55 | 58,48 | 57,55 | 58,48 | +2,04% | 1,63% | 19.396 |
| 23/03/1998 | 58,95 | 58,95 | 57,08 | 57,31 | -2,00% | 3,17% | 33.556 |
| 20/03/1998 | 59,42 | 59,89 | 58,48 | 58,48 | -1,96% | 2,36% | 22.175 |
| 19/03/1998 | 59,42 | 60,82 | 59,42 | 59,65 | -1,16% | 2,36% | 38.926 |
| 18/03/1998 | 60,82 | 62,23 | 58,95 | 60,36 | +4,88% | 5,38% | 91.772 |
| 17/03/1998 | 58,02 | 59,42 | 57,08 | 57,55 | -1,99% | 4,03% | 26.423 |
| 16/03/1998 | 60,82 | 60,82 | 58,25 | 58,72 | -1,95% | 4,23% | 49.907 |
| 13/03/1998 | 60,36 | 61,29 | 59,89 | 59,89 | +0,00% | 2,33% | 36.976 |
| 12/03/1998 | 60,82 | 60,82 | 58,72 | 59,89 | -0,39% | 3,46% | 54.689 |
| 11/03/1998 | 59,65 | 61,76 | 58,95 | 60,12 | +0,78% | 4,71% | 73.284 |
| 10/03/1998 | 59,65 | 59,89 | 58,95 | 59,65 | +0,79% | 1,57% | 55.865 |
| 09/03/1998 | 59,65 | 59,89 | 58,02 | 59,19 | +2,02% | 3,14% | 50.869 |
| 06/03/1998 | 58,02 | 58,72 | 58,02 | 58,02 | +0,00% | 1,21% | 69.543 |
| 05/03/1998 | 57,08 | 58,95 | 56,61 | 58,02 | -1,20% | 4,10% | 36.602 |
| 04/03/1998 | 57,55 | 58,95 | 56,61 | 58,72 | +2,45% | 4,07% | 66.364 |
| 03/03/1998 | 55,68 | 57,55 | 55,68 | 57,31 | +2,08% | 3,36% | 38.499 |
| 02/03/1998 | 56,61 | 57,08 | 55,68 | 56,14 | +0,00% | 2,48% | 62.891 |
| 27/02/1998 | 55,68 | 56,85 | 55,21 | 56,14 | +1,27% | 2,94% | 98.104 |
| 26/02/1998 | 55,21 | 55,68 | 54,74 | 55,44 | +0,42% | 1,70% | 37.590 |
| 25/02/1998 | 54,98 | 55,21 | 54,27 | 55,21 | +1,72% | 1,70% | 25.782 |
| 24/02/1998 | 54,27 | 54,74 | 53,81 | 54,27 | -0,85% | 1,72% | 39.674 |
| 23/02/1998 | 56,38 | 56,38 | 54,74 | 54,74 | +0,00% | 2,90% | 36.842 |
| 20/02/1998 | 54,74 | 56,14 | 52,87 | 54,74 | +0,00% | 5,98% | 118.916 |
| 19/02/1998 | 55,21 | 55,21 | 54,27 | 54,74 | -0,85% | 1,70% | 32.995 |
| 18/02/1998 | 55,21 | 57,08 | 54,27 | 55,21 | +1,72% | 5,08% | 104.115 |
| 17/02/1998 | 54,27 | 55,21 | 53,81 | 54,27 | +1,31% | 2,59% | 124.313 |
| 13/02/1998 | 54,27 | 54,51 | 52,40 | 53,57 | -1,29% | 3,88% | 133.156 |
| 12/02/1998 | 59,89 | 59,89 | 52,87 | 54,27 | +8,41% | 11,72% | 525.517 |
| 11/02/1998 | 51,70 | 51,93 | 49,13 | 50,06 | +1,90% | 5,43% | 72.589 |
| 10/02/1998 | 48,42 | 49,59 | 47,72 | 49,13 | +1,94% | 3,86% | 93.829 |